An Interest In:
Web News this Week
- March 17, 2024
- March 16, 2024
- March 15, 2024
- March 14, 2024
- March 13, 2024
- March 12, 2024
- March 11, 2024
May 31, 2018 02:40 pm
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/Hdza1S_sQDo/fda-halts-one-of-the-first-human-crispr-studies-before-it-begins
FDA Halts One of the First Human CRISPR Studies Before it Begins
A trial planning to use the gene-editing tool CRISPR on sickle cell patients has been put on hold due to unspecified questions from US regulators. From a report: CRISPR Therapeutics, which is developing the therapy, sought approval from the US Food and Drug Administration in April to begin the study. The therapy involves extracting stem cells from a patient's bone marrow and editing them with CRISPR in the lab. Once infused back into the patient, the idea is that the edited cells would give rise to healthy red blood cells. But according to a statement on Wednesday from CRISPR Therapeutics, the FDA ordered the company not to proceed with its study until it answers questions about its CRISPR treatment.Read more of this story at Slashdot.
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/Hdza1S_sQDo/fda-halts-one-of-the-first-human-crispr-studies-before-it-begins
Share this article:
Tweet
View Full Article
Slashdot
Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..More About this Source Visit Slashdot